Abstract: A rail apparatus includes first plate formed of a synthetic material having a first face and a second face opposite the first face, the first plate having a plurality of rows of spaced apart rail protrusions in a first pattern protruding from the second face of the first plate. A second metal plate includes a first face and a second face opposite the first face, the second plate having a plurality of rows of spaced apart slots in a second pattern matching the first pattern and extending through the first and second faces of the second plate. The second face of the first plate abutting the second face of the second plate, whereby the rows of rail protrusions extend through the slots and extend from the first face of the second plate.

Abstract: The present invention relates generally to viral vaccines and, more specifically, to filovirus vaccines and methods of eliciting an immune response against a filovirus or disease caused by infection with filovirus.

Abstract: The present invention relates generally to viral vaccines and, more specifically, to filovirus vaccines and methods of eliciting an immune response against a filovirus or disease caused by infection with filovirus.

Abstract: The present invention relates generally to viral vaccines and, more specifically, to filovirus vaccines and methods of eliciting an immune response against a filovirus or disease caused by infection with filovirus.

Abstract: Disclosed herein is a newly isolated human coronavirus (SARS-CoV), the causative agent of severe acute respiratory syndrome (SARS). Also provided are the nucleic acid sequence of the SARS-CoV genome and the amino acid sequences of the SARS-CoV open reading frames, as well as methods of using these molecules to detect a SARS-CoV and detect infections therewith. Immune stimulatory compositions are also provided, along with methods of their use.

Abstract: The present invention relates generally to viral vaccines and, more particularly, to filovirus vaccines and methods of eliciting an immune response against a filovirus or disease caused by infection with filovirus.

Abstract: An apparatus comprising a chassis defining an attachment slot suitable for receiving a first end of an expansion card and a bracket coupled to the chassis, the bracket movable into engagement with the expansion card closer to a second end than the first end when the expansion card is positioned in the attachment slot.

Abstract: A fan housing includes a shroud defining an air passageway. A housing member is located adjacent the air passageway and moveably coupled to the shroud such that the housing member is moveable relative to the shroud between an operating position and a service position. A fan housing is defined by the housing member, whereby the fan housing is inaccessible when the housing member is in the operating position and the fan housing is accessible when the housing member is in the service position. The shroud and housing member may be coupled to an information handling system chassis and adjacent a heat producing component. A fan may then be positioned in the fan housing when the housing member is in the service position. The housing member is then moved to the operating position and the fan is operated in order to cool the heat producing component.

Abstract: A fan housing apparatus includes a shroud defining an air passageway. A housing member is located adjacent the air passageway and moveably coupled to the shroud such that the housing member is moveable relative to the shroud between an operating position and a service position. A fan housing is defined by the housing member, whereby the fan housing is inaccessible when the housing member is in the operating position and the fan housing is accessible when the housing member is in the service position. The shroud and housing member may be coupled to an information handling system chassis and adjacent a heat producing component. A fan may then be positioned in the fan housing when the housing member is in the service position. The housing member is then moved to the operating position and the fan is operated in order to cool the heat producing component.

Abstract: An apparatus comprising a chassis defining an attachment slot suitable for receiving a first end of an expansion card and a bracket coupled to the chassis, the bracket movable into engagement with the expansion card closer to a second end than the first end when the expansion card is positioned in the attachment slot.

Abstract: Disclosed herein is a newly isolated human coronavirus (SARS-CoV), the causative agent of severe acute respiratory syndrome (SARS). Also provided are the nucleic acid sequence of the SARS-CoV genome and the amino acid sequences of the SARS-CoV open reading frames, as well as methods of using these molecules to detect a SARS-CoV and detect infections therewith. Immune stimulatory compositions are also provided, along with methods of their use.

Abstract: Disclosed herein are methods of reducing infection of a cell by a pathogen, for example to treat or prevent a pathogen infection. Exemplary pathogens include those that use a lipid raft. The disclosure also relates to methods of identifying agents involved in pathogen infection, such as modulators of Rab9A and Rab11A.

Abstract: Host nucleic acids and host proteins that participate in viral infection, such as human immunodeficiency virus (HIV), influenza A, and Ebola virus, have been identified. Interfering with or disrupting the interaction between a host nucleic acid or host protein and a virus or viral protein confers an inhibition of or resistance to infection. Thus, interfering with such an interaction in a host subject can confer a therapeutic or prophylactic effect against a virus. The sequences identified can be used to identify agents that reduce or inhibit viral infection.

Abstract: Tripeptide and tetrapeptide thioethers, pharmaceutical compositions containing them, their pharmaceutical use, and their preparation. The compounds are useful in potentiating the cytotoxic effects of chemotherapeutic agents in tumor cells, selectively exerting toxicity in tumor cells, elevating the production of GM progenitors in bone marrow, stimulating the differentiation of bone marrow, mitigating the myelosuppressive effects of chemotherapeutic agents, and modulating hematopoiesis in bone marrow.

Abstract: Pseudotyped retroviruses having viral glycoproteins with modified O glycosylation regions are provided. Also provided are methods for making the pseudotyped retroviruses of the present invention and for using the pseudotyped retroviruses for transduction of target cells. Cells for stably producing the pseudotyped retroviruses or the present invention are also provided.

Abstract: Ebola virus vaccines comprising nucleic acid molecules encoding Ebola viral proteins are provided. In one embodiment, the nucleic acid molecule encodes the transmembrane form of the viral glycoprotein (GP). In another embodiment, the nucleic acid molecule encodes the secreted form of the viral glycoprotein (sGP). In yet another embodiment, the nucleic acid molecule encodes the viral nucleoprotein (NP). Methods for immunizing a subject against disease caused by infection with Ebola virus are also provided.

Abstract: Ebola virus vaccines comprising nucleic acid molecules encoding Ebola viral proteins are provided. In one embodiment, the nucleic acid molecule encodes the transmembrane form of the viral glycoprotein (GP). In another embodiment, the nucleic acid molecule encodes the secreted form of the viral glycoprotein (sGP). In yet another embodiment, the nucleic acid molecule encodes the viral nucleoprotein (NP). Methods for immunizing a subject against disease caused by infection with Ebola virus are also provided.

Abstract: In one embodiment, a media handling system is provided to transfer media through an image forming device having a primary media path and a duplex media path. The media handling system includes a media feeder configured to input media into the duplex media path of the image forming device.

Abstract: The present invention relates generally to viral vaccines and, more particularly, to filovirus vaccines and methods of eliciting an immune response against a filovirus or disease caused by infection with filovirus.